The bottom line: the trend of improvement continues but with a fairly slow decline in new cases in the countries that have been hit the worst, like Italy, Spain and the US. Singapore continues to see challenges and extends lockdown measures to 1 June. Focus on trial results of the drugs Remdesivir and Kevzara expected over the coming week.

Read the full article on Danske Bank Research's website